Stock listing

TSXV:TLT Theralase Technologies Inc. Stock

Home listing (TSXV) of Theralase Technologies Inc.

Follow Theralase Technologies Inc. into a list and get an email when it puts out news.

Share price · TSXV:TLT

$0.19 CAD +0.01 (+5.6%)

Close on Oct 14, 2026

Theralase Technologies Inc. logo
Ticker
TSXV:TLT
Asset type
Stock
Sector
Health care
Industry
Biotechnology
Exchange
TSXV
Currency
CAD

What changed lately

Latest news

All Theralase Technologies Inc. news

Financings

  • Private placement of units

    Sep 18, 2026

    Closed: C$3.56M in the latest tranche · C$0.24 a unit · 1 warrant at C$0.32 · Research Capital Corporation

    Dealers: Research Capital Corporation (lead)

    Insiders: An aggregate of 116,250 Units, representing gross proceeds of $27,900, were issued to certain insiders of the Company

    Use of proceeds: GLP toxicology studies for intravenous Rutherrin in cancers and topical Ruvidar for cold sores; working capital and general corporate purposes

    Announced Aug 10, 2026 · Closed Aug 24, 2026 · Closed Aug 28, 2026 · Closed Sep 18, 2026

Read by 6ix AI from the company's releases

Decks

Theralase Technologies Inc. on 6ix

Sector
Health care
Industry
Biotechnology
News releases
35 in the last 12 months · 246 in all · newest Oct 9, 2026 · oldest 2017
Decks
5 decks · latest Feb 17, 2026

Where Theralase Technologies Inc. is listed

ListingExchangeCountryCurrency
TSXV:TLT · Home listing · This pageTSXVCanadaCAD
OTC:TLTFFOTCUnited StatesUSD
Cboe Canada:TLTCboe CanadaCanadaCAD
Lang & Schwarz:A0DLB7Lang & SchwarzGermanyEUR
LS Exchange:A0DLB7LS ExchangeGermanyEUR
Frankfurt:TTXFrankfurtGermanyEUR
Stuttgart:TTXStuttgartGermanyEUR
Dusseldorf:TTXDusseldorfGermanyEUR

Log in to ask 6ix AI your own questions about Theralase Technologies Inc.